AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

8,845.00p
   
  • Change Today:
    177.00p
  • 52 Week High: 8,982.00
  • 52 Week Low: 6,794.00
  • Currency: UK Pounds
  • Shares Issued: 1,549.13m
  • Volume: 4,348,813
  • Market Cap: 137,020m
  • RiskGrade: 123

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 2.3% 2.5%
Div Cover 0.9 2.0
Op Mrgn 19.4% 26.3%
ROCE 76.3%  
Latest F'cast
P/E 49.6 22.1
PEG 0.4 0.2
Pr/Revenue 7.0 5.4
Pr/Book 12.0  
Latest F'cast
Revenue 9.2% -30.2%
PBT 153.0% 25.0%
EPS 136.9% 125.0%
DPS n/a -46.9%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 23,002.00 3,552.00 431.00¢ 14.1 14.1 +1% 280.00¢ 4.6%
31-Dec-17 22,465.00 2,227.00 428.00¢ 16.4 n/a -1% 280.00¢ 4.0%
31-Dec-18 22,090.00 1,993.00 170.00¢ 47.2 n/a -60% 280.00¢ 3.5%
31-Dec-19 24,384.00 1,548.00 103.00¢ 101.0 n/a -39% 280.00¢ 2.7%
31-Dec-20 26,617.00 3,916.00 244.00¢ 41.0 0.3 +137% 280.00¢ 2.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 25,404.22 6,692.47 399.89p 22.1 0.2 +125% 203.12p 2.5%
31-Dec-22 30,586.53 9,503.40 524.93p 16.8 0.5 +31% 210.22p 2.6%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Lynparza PROpel trial meets primary endpoint 24-Sep-2021 07:00 RNS
New Sustainability Committee of the Board 23-Sep-2021 07:00 RNS
Board Committee Change 23-Sep-2021 07:00 RNS

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 8,845.00p
Change Today 177.00p
% Change 2.04 %
52 Week High 8,982.00
52 Week Low 6,794.00
Volume 4,348,813
Shares Issued 1,549.13m
Market Cap 137,020m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
81.46% below the market average81.46% below the market average81.46% below the market average81.46% below the market average81.46% below the market average
32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average
Price Trend
24.97% above the market average24.97% above the market average24.97% above the market average24.97% above the market average24.97% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average
Income
27.67% below the market average27.67% below the market average27.67% below the market average27.67% below the market average27.67% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Growth
87.79% above the market average87.79% above the market average87.79% above the market average87.79% above the market average87.79% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average

What The Brokers Say

Strong Buy 23
Buy 2
Neutral 2
Sell 0
Strong Sell 1
Total 28
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 12-Aug-21 25-Feb-21
Paid 13-Sep-21 29-Mar-21
Amount 90.00¢ 190.00¢

Trades for 24-Sep-2021

Time Volume / Share Price
16:07 200,000 @ 8,900.00p
15:57 200,000 @ 8,900.00p
16:45 100 @ 8,840.00p
16:45 100 @ 8,840.00p
16:35 85,000 @ 8,845.00p

Top of Page